Pradaxa, also known by its generic name, dabigatran, is an anticoagulant, a type of medication used to prevent the clotting of blood. Pradaxa is a thrombin inhibitor, which works by blocking the body’s natural chemical reaction to clot blood by preventing thrombin (an enzyme) from forming. Pradaxa has been an alternative choice to warfarin, an anticoagulant that has been on the market for many years.
Pradaxa was first FDA approved in 2010 and is manufactured by Boehringer Ingelheim. It is FDA approved for treatment in the reduction of the risk of stroke in patients with non-valvular atrial fibrillation, as well as, treatment for deep vein thrombosis (DVT) and pulmonary embolism.
However, since its arrival on the market, Pradaxa has been linked to thousands of adverse events. As of 2010, the FDA has received over 4,000 reports of negative side effects and more than 500 deaths among those who have used the drug. The most serious medical complication is uncontrolled internal bleeding. Different types of internal bleeding associated with Pradaxa are gastrointestinal bleeding, brain bleeding, and severe rectal bleeding.
Side effects of taking Pradaxa include:
- Unusual/easy bruising
- Easy/continuous bleeding
- Pink or brown urine
- Frequent nose bleeds
- Bleeding gums
- Coughing up blood
- Swelling or joint pain
At McDivitt Law Firm, we feel that you deserve information that may be relevant to your rights as a consumer. We want to alert you to a potential claim regarding this medication that you or someone you know may have been prescribed.
We may be able to help you if you have experienced uncontrollable bleeding or other serious side effects after use of Pradaxa. Call us today to discuss your potential claim in detail and to help you through this trying time.